Malignant Pleural Mesothelioma Caused by Environmental Exposure to Asbestos in the Southeast of Turkey: CT Findings in 117 Patients

Size: px
Start display at page:

Download "Malignant Pleural Mesothelioma Caused by Environmental Exposure to Asbestos in the Southeast of Turkey: CT Findings in 117 Patients"

Transcription

1 Clinical Investigations Respiration 2000;67: Received: August 6, 1999 Accepted after revision: June 27, 2000 Malignant Pleural Mesothelioma Caused by Environmental Exposure to Asbestos in the Southeast of Turkey: CT Findings in 117 Patients A. Şenyı ğı t a H. Bayram a C. Babayı ğı t a F. Topçu a H. Nazaroğlu b A. Bı lı cı a İ.H. Leblebı cı a a Department of Chest Diseases and b Department of Radiodiagnostics, Faculty of Medicine, University of Dicle, Diyarbakır, Turkey For editorial comment see p Key Words Mesothelioma W Computed tomography W Environmental asbestos exposure Abstract Background and Objectives: Malignant pleural mesothelioma (MPM) is reported to be common in the southeast of Turkey, as a result of environmental asbestos exposure. The aim of this study was to evaluate the computed tomography (CT) features of MPM in patients with a history of asbestos exposure. Methods: The CT scans of 117 patients who had a diagnosis of MPM were retrospectively evaluated. Additionally, CT findings of histologic subtypes were compared. Results: The most common CT findings included pleural effusion (n = 104, 89%), pleural thickening (n = 96, 82%), mediastinal pleural involvement (n = 77, 66%) and interlobar fissural involvement (n = 62, 53%). Histologic subtype analysis was performed in 89 patients; of these, epithelial, sarcomatous and mixed types were identified in 46, 23 and 20 patients, respectively. An analysis of CT findings demonstrated that the involvement of mediastinal pleural (91%), interlobar fissure (87%) and lung parenchyma (48%) was significantly more frequent in sarcomatous type, as compared to epithelial (61% and p! 0.01; 35 and 4%, p! , respectively) and mixed types (65% and p! 0.05; 10% and p! ; 10% and p! 0.01, respectively). Furthermore, there was a significant correlation between pericardial involvement and chest wall involvement (r = 0.42, p! 0.05) in sarcomatous type. Similarly, lymphadenopathy and parenchymal involvement (r = 0.23, p! 0.02), pericardial and chest wall involvement (r = 0.25, p! 0.01), chest wall and interlobar fissural involvement (r = 0.25, p! 0.01) were significantly correlated, when CT findings of all histologic subtypes were combined. Conclusions: These results suggest that although CT findings of MPM vary, they may provide valuable clues to the diagnosis, at least in patients with a history of asbestos exposure. In addition, the presence of extensive lesions may suggest MPM of sarcomatous subtype. Copyright 2000 S. Karger AG, Basel ABC Fax karger@karger.ch S. Karger AG, Basel /00/ $17.50/0 Accessible online at: Abdurrahman Şenyı ğı t Tıp Fakültesi Göğüs Hastalıkları, Diyarbakır (Turkey) Tel /4287 or 4270, Fax , senyigit@dicle.edu.tr

2 Introduction Malignant pleural mesothelioma (MPM) is a primary pleural tumor of mesodermal origin [1]. In the etiology, exposure to asbestos fibers is the most frequent cause, though fibrous zeolite (erionite) and radiation are also among the etiologically important factors [2 6]. MPM is endemically present in some regions of Turkey including several provinces in the southeast of the country, as a result of exposure to environmental fibrous minerals [7]. Yazıcıoğlu [8] and Yazıcıoğlu et al. [9] previously reported that people born or living in some districts of Diyarbakır, Elazıg and Şanlıurfa are exposed to soil containing serpentine and amphibole asbestos fibers and talc, which have no economic value. The material containing asbestos is quarried from mountains by men for both local use and sale in neighboring towns. It is used as a whitewash material for the walls and floors of the houses, and this procedure is repeated every year. Thus, householders are repeatedly exposed to asbestos fibers in their environment, from an early age [9, 10]. The diagnosis of pleural mesothelioma is difficult and often delayed for 6 8 months after the initial symptoms [11]. Cytological examination of pleural effusion, percutaneous transthoracic needle biopsy and even diagnostic thoracoscopy are sometimes insufficient for diagnosis [12]. In such circumstances computed tomography (CT), as a noninvasive procedure, may contribute to the diagnosis, although none of the findings are pathognomonic [13]. In this study, we have evaluated CT findings in 117 cases of MPM caused by environmental exposure to asbestos fibers. We have also investigated the frequency of CT findings in patients whose histologic subtype of disease was identified. diagnoses of MPM were pathologically confirmed in all cases, and the histologic subtype, where noted, was included. Thorax CT was performed in all cases after hospitalization, using a Toshiba TCT 600S CT device and Toshiba X vision GX (Otowara City, Naso, Japan). Evaluation was carried out in chest images obtained in 10-mm slices from the apices of the lungs to costophrenic angles. All of the sections were taken in the supine position at the end of the inspirium. Both mediastinal and parenchymal window settings were used. Intravenous iodinated contrast medium was given to the patients with normal respiratory function to determine mediastinal lymph node enlargement and/or the relation of the lesions to adjacent vascular structures. The CT scans were evaluated by a team of 3 pneumologists and 4 radiologists. A conclusion was reached by consensus. On CT scans, pleural thickening was classified as diffuse, mass type and nodular, and the localization of pleural effusion as ipsilateral and bilateral. In cases of different types of pleural thickening in the same individual, each type was noted separately. Dislocation of the mediastinal structures due to pleural lesions was defined as mediastinal shift. Contraction of the involved hemithorax or mediastinal displacement, distortion of the bronchovascular structures, elevation of the ipsilateral hemidiaphragm and compensatory hyperinflation of contralateral lung were evaluated as volume contraction. Thickening of the pleura of 10 mm or less was defined as pleural thickening, and mm focal pleural thickening as pleural nodule. Pleura-based soft tissue mass with a width of 30 mm or more was referred to as pleural mass. Transversal or craniocaudal pleural thickening less than 50 mm in length was noted as pleural plaque. Mediastinal lymph nodes were considered pathologically as enlarged, if they were greater than 10 mm in short-axis diameter in the transverse plane. Involvement of interlobar fissures and mediastinal pleura were also noted. Furthermore, an association between CT findings and histologic subtypes (i.e. epithelial, sarcomatous and mixed) was investigated in cases whose histologic subtype of disease was identified. Statistical Analysis Student s t test was applied to determine the significance of any differences between CT findings in subgroups of patients with epithelial, sarcomatous or mixed histologic subtypes. Furthermore, the association between CT findings within histologic subtypes was tested using Pearson s correlation coefficient, and all values of p! 0.05 were considered to be significant. Materials and Methods The CT scans of 117 patients (67 men and 50 women) who were diagnosed as having MPM at the Departments of Chest Diseases and Tuberculosis, and Chest Surgery, Dicle University Research Hospital, Diyarbakır, Turkey, between January 1988 and March 1999 were retrospectively evaluated. All patients had a history of environmental asbestos exposure, and their mean age was 53.2 years with a range of years. The diagnosis was made on the basis of pleural tissue obtained using Ramel needle biopsy, cytologic examination and by videoassisted thoracoscopic surgery (VATS) in 96 (82%), 8 (7%), and 13 cases (11%), respectively. Thirteen patients had no pleural effusion; of these, 4 were diagnosed by VATS, 3 by transthoracic needle biopsy, and 6 by CT or ultrasonography-guided Ramel needle biopsy. The Results The evaluation of CT scans obtained from 117 patients demonstrated that the right hemithorax was affected more frequently in 82 patients (70%) as compared to the left hemithorax in 30 patients (26%), and bilateral involvement was found in 5 patients (4%). Most of the patients had pleural effusion (89%), and the effusion was encapsulated in 6 patients. Pleural thickening was present in 96 patients (fig. 1), and mediastinal pleural involvement in 77 patients. Additionally, pleural plaques were present in 21% of our cases; of 18% with hyaline and 3% 616 Respiration 2000;67: Şenyı ğı t/bayram/babayı ğı t/topçu/ Nazaroğlu/Bı lı cı /Leblebı cı

3 Fig. 1. Nodular pleural thickening in the lateral right hemithorax. Fig. 2. Minimal pleural thickening with calcification on the medial side of the left hemithorax, and pleural effusion together with calcified pleural plaques in the right hemithorax. Although malignity was not detected in the left pleura, MPM was diagnosed by biopsy obtained using thoracoscopy on the right side. Fig. 3. Irregular pleural thickening, mediastinal pleural involvement, and volume contraction accompanied by posterior costal invasion indicating chest wall involvement in the right hemithorax. Fig. 4. A heterogeneous mass filling the right hemithorax completely with localized anterior-lateral chest wall involvement. The mediastinum is shifted to the left because of the mass. Sarcomatous subtype MPM was diagnosed using closed pleural needle biopsy. with calcified pleural plaques (fig. 2). Atelectasis was detected in 30 cases, and it was rounded in 4 patients and compressional in 26 patients due to pleural effusion. Pericardial involvement was found in 7 cases, while 3 had no pericardial effusion. Ten patients had chest wall involvement; 8 patients demonstrated costal involvement (fig. 3) and 2 vertebral destruction. In 2 patients with chest wall invasion, the hemithorax was found to be completely filled with large tumor masses on the same side (fig. 4). However, CT did not indicate any pleural pathology, but pleural effusion in 3 cases, who subsequently underwent VATS, and the diagnosis was made by biopsies taken from tiny nodular lesions on visceral pleura (fig. 5). CT findings of patients are presented in table 1. Mesothelioma and CT Findings Respiration 2000;67:

4 Fig. 5. A pleural effusion in the right hemithorax without pleural thickening or mass. The diagnosis was made by biopsies taken from tiny nodular lesions on visceral pleura under thoracoscopy. Fig. 6. In the left hemithorax, there was an indication of parenchymal involvement accompanied by nodular pleural thickening in a patient diagnosed as sarcomatous type MPM. Parenchymal involvement was confirmed by thoracotomy. Table 1. CT findings in 117 patients with MPM Radiological findings Patients Pleural effusion Ipsilateral Bilateral 5 4 Pleural thickening Diffuse Nodular Mass type 9 8 Mediastinal pleural involvement Interlobar fissural involvement Volume contraction Mediastinal shift Atelectasis Lymphadenopathy Pleural plaques Calcified 4 3 Hyaline No effusion Involvement of lung parenchyma Chest wall invasion 10 9 Pericardial involvement 7 6 Normal pleural appearance (only effusion) 3 3 Involvement of Diaphragmatic pleura 3 3 Pneumothorax 1 1 Table 2. The chest X-ray findings in environmental asbestos-related MPM Radiological finding Patients Pleural effusion Pleural thickening Volume contraction Mediastinal shift Mediastinal pleural thickening Pleural calcification Pleural nodule 8 7 Fissural thickening 7 6 Cardiomegaly 3 3 Paratracheal nodule 2 2 Pneumothorax 1 1 The most common chest X-ray findings included pleural effusion (86%), pleural thickening (33%), volume contraction (32%) and mediastinal shift (29%). Additionally, X-ray indicated mediastinal pleural thickening in 21% of the cases, however, this was detected in 9% of cases with massive pleural effusion (table 2). Histologic subtype analysis was performed in 89 patients in total. Of these, epithelial, sarcomatous and mixed types were identified in 46, 23 and 20 patients, respectively. The statistical analysis of CT findings seen in histologic subtypes demonstrated that the mediastinal 618 Respiration 2000;67: Şenyı ğı t/bayram/babayı ğı t/topçu/ Nazaroğlu/Bı lı cı /Leblebı cı

5 Table 3. CT findings in different histologic subtypes of MPM CT finding Epithelial (n = 46) Sarcomatous (n = 23) Mixed (n = 20) Pleural thickening Diffuse Nodular Mass type Mediastinal pleural involvement b c No effusion Normal pleura (only effusion) Lymphadenopathy 3 7 a Volume contraction Mediastinal shift Pericardial involvement Chest wall invasion 1 2 b Interlobar fissural involvement b d Involvement of lung parenchyma 2 4 b, e d Number and percent of cases. a p! 0.05 and b p! 0.01 vs. sarcomatous type, c p! 0.05 and d p! 0.01 vs. sarcomatous type, e p! 0.05 vs. mixed type. pleural involvement of tumor was significantly more frequent in sarcomatous type (91%), as compared to epithelial (61% and p! 0.01) and mixed types (65% and p! 0.05). Similarly, the involvement of interlobar fissure and lung parenchyma (fig. 6) was found to be significantly higher in sarcomatous type (87 and 48%, respectively) than in both epithelial (35 and 4%, respectively; p! ) and mixed types (10% and p! for interlobar fissural involvement, and 10% and p! 0.01 for involvement of lung parenchyma). Furthermore, lymphadenopathy (26% and p! 0.05) and chest wall invasion (22% and p! 0.01) were significantly increased in sarcomatous type, when compared to epithelial type (7 and 2%, respectively). A comparison between CT findings detected in epithelial and mixed types demonstrated that involvement of lung parenchyma was significantly more frequent in mixed type (10% and p! 0.05) as compared to epithelial type (4%). CT findings in all histologic subtypes are shown in table 3. Looking at correlations between CT findings within subtypes we found that pericardial involvement was significantly correlated with chest wall involvement (r = 0.42; p! 0.05) only in sarcomatous type. However, when CT findings in all subtypes were considered, there was a significant correlation between lymphadenopathy and parenchymal involvement (r = 0.23 and p! 0.02), pericardial involvement and chest wall involvement (r = 0.25 and p! 0.01), and between chest wall involvement and interlobar fissural involvement (r = 0.25 and p! 0.01) in all histologic subtypes. Discussion In the present study, we retrospectively analyzed CT findings of 117 patients with MPM caused by environmental asbestos exposure. Furthermore, we investigated whether there was any difference between the frequency of CT findings seen in patient groups with different histologic subtypes of MPM. The evaluation of CT scans demonstrated that pleural effusion, pleural thickening, mediastinal pleural involvement, interlobar fissural involvement and volume contraction were the most common CT findings. Moreover, we found that the involvement of mediastinal pleura, interlobar fissure and lung parenchyma was more common in cases with sarcomatous type as compared to both epithelial and mixed types. Analysis of CT findings in patients whose histologic subtype was determined demonstrated that lymphadenopathy and parenchymal involvement, involvement of pericardium and chest wall, and involvement of chest wall and interlobar fissure were correlated. It has been reported that chest X-ray findings are usually nonspecific and insufficient for diagnosis of MPM Mesothelioma and CT Findings Respiration 2000;67:

6 [14, 15], and that most common radiographic findings include pleural effusion, diffuse irregular pleural thickening, pleural masses and to a lower extent destruction of costae [12, 16]. Nevertheless, chest X-rays may be important, particularly in the presence of pleural thickening and/or lobulated masses. Volume contraction because of coverage of the lung by the fibrous component of the tumor, depression of the ipsilateral shoulder and findings of fixed chest may also be detected by X-ray. However, CT is known to be more accurate and reliable in diagnosing and determining the extent of mesothelioma [17, 18]. Selçuk et al. [3] reported that the involvement of the mediastinal pleura and interlobar fissure was more detectable in CT scans compared to chest X-rays. Similarly, we found that involvement of interlobar fissure and mediastinal pleura was not visible on chest X-rays of patients with massive pleural effusion, and although chest X-rays showed these pathologies in only 6 and 21% of patients, involvement of interlobar fissure and mediastinal pleura were detected in 53 and 66% of the cases by CT. Furthermore, our finding that pleural thickening was detected in 82% of cases compared with 33% by X-ray is in accordance with the report by Adams et al. [11] suggesting that pleural thickening may not be seen because of pleural effusion. Although pleural effusion is frequently present in MPM in % of cases with MPM [15], it is not a specific finding for MPM [9, 11]. We detected pleural effusion in 89% of our cases. However, in some cases, pleural effusion may be the only finding without prominent pleural mass or thickening [3]. Confirming this, Leung et al. [13] reported pleural effusion as a unique finding of neoplastic involvement in 7.6% of their cases. Hence, it has been proposed not to exclude a possible diagnosis of MPM in the absence of pleural thickening [13,19]. For instance, Maffessanti et al [19] reported malignant pleural effusion in 7 of 12 cases with normally appearing pleura, while Yılmaz et al. [7] detected MPM in 1 of 46 cases with MPM having no pleural thickening. In our study, we diagnosed MPM in 3% of cases who presented pleural effusion without pleural thickening or pleural plaques. These 3 cases were subjected to VATS, and the diagnosis was established by pleural biopsies from tiny nodular lesions which were not visible on CT scans. Thus, we think MPM should be considered in the diagnosis of cases with pleural effusion and a history of asbestos exposure, and further investigation should be carried out, although CT appearance of the pleura is rarely normal initially. CT is also thought to allow a precise characterization of the different types of pleural thickening [20]. Diffuse pleural thickening is a manifestation of asbestos exposure, although its presence is usually less frequent than pleural plaques. When nodular pleural thickening is detected alone, it is difficult to distinguish it from MPM [21]. The presence of regular and slightly thickened pleura with irregular nodular masses is the most prominent feature of MPM, though it is not pathognomonic [22]. We detected nodular pleural thickening in 21% of our cases, while Leung et al. [13] reported 63%. It is possible that this discrepancy was a result of the fact that our cases were in advanced stages at which diffuse pleural thickening had already developed. The interlobar fissural involvement and atelectasis together with pleural thickening are reported to be the earliest findings of MPM detectable by CT [2], and although free or localized pleural effusion and pleural thickening resulting from fibrosis can involve the interlobar fissures, these were reported to cause smooth thickening of the fissures rather than the irregular or nodular thickening produced by MPM [11]. It is also thought difficult to differentiate a sole pleural thickening from effusion, especially when nodularity is absent in the fissure [7, 23]. Overall, interlobar fissural involvement was present in 53% of our cases, which is less than the previously reported % [3, 14, 23]. Ipsilateral volume contraction resulting from the involvement of the pleural compartment is reported to be common in patients with MPM [22]. The fixation of the mediastinum and volume contraction at the involved site were suggested as diagnostic features of MPM [23], but they have, in fact, less value since they may also be present in some benign and malignant diseases of the chest [13, 22]. Several studies reported volume contraction in 42 73% [6, 13, 14, 22, 23]. Similarly, we detected this pathology in 51% of our cases. Pleural plaques are the most common radiological manifestation of asbestos exposure, nevertheless, it may sometimes be difficult to detect this pathology by conventional chest radiography. Baker and Greene reported that only 68% of pleural plaques were visible on chest X-rays, and that they were more prominent on oblique scans [21]. Although calcified pleural plaques are usually regarded as benign lesions [24], MPM may also be considered in differential diagnosis, especially when there is unilateral effusion coexisting [3]. It has been reported that there was evidence of pleural plaques in a substantial number of cases with MPM [25]. We detected pleural plaques in 21% of our cases, 18% with hyaline and 3% with calcified pleu- 620 Respiration 2000;67: Şenyı ğı t/bayram/babayı ğı t/topçu/ Nazaroğlu/Bı lı cı /Leblebı cı

7 ral plaques. This is in accordance with the results reported by Kawashima and Libshitz [23] (20%) and Leung et al. [13] (27%), although the latter is slightly higher. We demonstrated that pleural plaques had irregular margins in all patients having pleural plaques, except 1 case. Furthermore, biopsy specimens obtained from the pleural plaques showed malignant degeneration in 2 of 5 cases who underwent thoracotomy. This suggests that the development of irregular plaques in the presence of smooth plaques may not be sufficient evidence for malignant degeneration. In their study comparing the radiological findings of mesothelioma and asbestosis, Rabinowitz et al. [18] reported that irregular plaques alone were not a criterion of malignancy. Furthermore, these authors suggested that a plaque is not a static structure, since active inflammatory changes are associated with pleural asbestosis, and that a plaque may continue to grow and alter its configuration periodically [18]. Calcified pleural plaques were rarely seen, in only 3% of our cases. Similarly, Rabinowitz et al. [18] reported that these plaques were infrequently encountered in mesothelioma either via CT or radiography, and suggested that this could be a result of the absorption of the calcification by the tumor [13]. Diffuse mesothelioma frequently encases the entire lung, although the greatest region of tumor growth is usually the surface of the lower lobes. This tumor generally spreads locally [1], and may be detected as nodular masses which can be classified according to their source of origin as parenchymal extension or intraparenchymal. Parenchymal extension has been reported to contain pleural-based nodular masses extending into lung, whereas intraparenchymal masses were found to be round, sharply demarcated and located within the lung [18]. In our study, we detected lung penetration in 12 patients (10%), and these were pleural-based masses that extended into lung parenchyma. In 11 patients, the attachment to pleura was on a thin pedicle and in 1 case on a broad base. However, we have not detected any intraparenchymal lesions isolated from pleura. The histopathological examination of tissue obtained from these lesions has revealed MPM. Similarly, Rabinowitz et al. [18] reported that the intraparenchymal lesions histologically represented malignant mesothelioma in patients with mesothelioma, and thickened pleura in patients with asbestosis. Although the degree of therapeutic efficacy is reported to be closely related to the histologic structure of the tumor [18], to our knowledge, there are no or limited studies investigating CT features of histologic subtypes of MPM in large series. In the present study, however, the frequency of most CT findings detected in all three subtypes was not different. The only significant differences were that involvement of mediastinal pleura, interlobar fissure and lung parenchyma was more frequent in sarcomatous type compared to both epithelial and mixed types. Additionally, we found that pericardial involvement and lymphadenopathy were less frequent in epithelial type as compared to sarcomatous type, and 2 cases in the epithelial group did not show any pleural pathology. Thus, although the presence of extensive lesions suggested sarcomatous type, there was no significant difference in the localization and characteristic of the tumor (as being diffuse, nodular or mass type). It has been suggested that epithelial mesotheliomas differ from those with sarcomatoid histology with regard to clinical course and presentation. The former are reported to behave similarly to metastatic carcinomas to the pleura in that they present with large pleural effusions and metastases to regional lymph nodes, while the latter are thought to be more similar to pleural sarcomas in presenting with bulky tumor masses, minimal pleural fluid, and blood-borne metastases [25]. Our results have also indicated that there was a correlation between lymphadenopathy and parenchymal involvement, pericardial involvement and chest wall involvement, and between chest wall involvement and interlobar fissural involvement, when CT findings in all histologic subtypes are considered. To our knowledge, there are limited or no studies from the literature reporting such a correlation. Although it is possible that this may be related to the extent of the disease, we think, the significance of such a correlation remains to be determined. In conclusion, our results have demonstrated that although CT findings of MPM vary, they may provide valuable clues to the diagnosis, at least in patients with a history of asbestos exposure. Additionally, the fact that several CT findings such as the involvement of mediastinal pleura, interlobar fissure and lung parenchyma were more frequent in cases with sarcomatous type may be evidence of the invasive character of this tumor. Acknowledgement We thank Dr. Ömer Satıcı from the Biostatistics Department, School of Medicine, University of Dicle for his advice on the statistical analysis of the data. Mesothelioma and CT Findings Respiration 2000;67:

8 References 1 Patz EF Jr, Shaffer K, Piwnica-Worms DR, Jochelson M, Sarin M, Sugarbaker DJ, Pugatch RD: Malignant pleural mesothelioma: Value of CT and MR imaging in predicting resectability. AJR 1992;159: Aisner J: Current approach to malignant mesothelioma of the pleura. Chest 1995;107 (suppl): Selçuk ZT, Çöplü L, Emri S, Kalyoncu AF, Şahin AA, Barış Yİ: Malignant pleural mesothelioma due to environmental mineral fiber exposure in Turkey: Analysis of 135 cases. Chest 1992;102: Nishimura SL, Broaddus VC: Asbestos-induced pleural disease. Clin Chest Med 1998; 19: Türler A, Mönig SP, Raab M: Problems in diagnosis and therapy of malignant pleural mesothelioma. Med Klin 1997;92: Şahin AA, Çöplü L, Selçuk ZT, Eryılmaz M, Emri S, Akhan O, Barış Yİ: Malignant pleural mesothelioma caused by environmental exposure to asbestos or erionite in rural Turkey: CT findings in 84 patients. AJR 1993;161: Yılmaz UM, Utkaner G, Yalnız E, Kumcuoglu Z: Computed tomographic findings of environmental asbestos-related malignant pleural mesothelioma. Respirology 1998;3: Yazıcıoǧlu S: Pleural calcification associated with exposure to chrysotile asbestos in Southeast Turkey. Chest 1976;70: Yazıcıoǧlu S, İlçayto R, Balcı K, Saylı BS, Yorulmaz B: Pleural calcification, pleural mesotheliomas, and bronchial cancers caused by tremolite dust. Thorax 1980;35: Topçu F, Bayram H, Şimşek M, Kaya K, Özcan C, Işık R, Şenyiǧit A: High-resolution computed tomography in cases with environmental exposure to asbestos in Turkey. Respiration 2000;67: Adams VI, Unni KK, Muhm JR, Jett JR, Ilstrup DM, Bernatz PE: Diffuse malignant mesothelioma of pleura. Diagnosis and survival in 92 cases. Cancer 1986;58: Işık R, Şimşek M, Coşkunsel M, Bükte Y: CT findings in diagnosis of malignant mesothelioma. Tüberküloz ve Toraks 1993;41: Leung AN, Müller NL, Miller RR: CT in differential diagnosis of diffuse pleural disease. AJR 1990;154: Erzen C, Eryılmaz M, Kalyoncu F, Bilir N, Şahin A, Barış Yİ: CT findings in malignant pleural mesothelioma related to nonoccupational exposure to asbestos and fibrous zeolite (erionite). J Comput Assist Tomogr 1991;15: Rusch VW, Godwin JD, Shuman WP: The role of computed tomography scanning in the initial assessment and the follow-up of malignant pleural mesothelioma. J Thorac Cardiovasc Surg 1988;96: Bilici A, Uyar A, Özateş M: CT features of malignant pleural mesothelioma. Dicle Üniv Tıp Fak Derg 1994;21: Alexander E, Clark AC, Colley DP, Mitchell SE: CT of malignant pleural mesothelioma. AJR 1981;137: Rabinowitz JG, Efremidis SC, Cohen B, Dan S, Efremidis A, Chahinian AP, Teirstein AS: A comparative study of mesothelioma and asbestosis using computed tomography and conventional chest radiography. Radiology 1982;144: Maffessanti M, Tommasi M, Pellegrini P: Computed tomography of free pleural effusions. Eur J Radiol 1987;7: Gevenois PA, Trogrlic S: Imaging of the pleura. Rev Prat 1997;47: Miller WT Jr, Gefter WB, Miller WT Sr: Asbestos-related chest diseases: Plain radiographic findings. Semin Roentgenol 1992;27: Çakmak F, Kuranel BB, Ünsal M, Işık S: Computed tomographic findings in malignant pleural mesothelioma. Solunum Hastalıkları 1993; 4: Kawashima A, Libshitz HI: Malignant pleural mesothelioma: CT manifestations in 50 cases. AJR 1990;155: Munden RF, Libshitz HI: Rounded atelectasis and mesothelioma. AJR 1998;170: Albelda SM, Sterman DH, Litzky LA: Malignant mesothelioma and other primary pleural tumors; in Fishman AP (ed): Fishman s Pulmonary Diseases and Disorders. New York, McGraw-Hill, 1998, pp Respiration 2000;67: Şenyı ğı t/bayram/babayı ğı t/topçu/ Nazaroğlu/Bı lı cı /Leblebı cı

Incidence of Malignant Pleural Mesothelioma due to Environmental Asbestos Fiber Exposure in the Southeast of Turkey

Incidence of Malignant Pleural Mesothelioma due to Environmental Asbestos Fiber Exposure in the Southeast of Turkey Clinical Investigations Respiration 2000;67:610 614 Received: November 26, 1999 Accepted after revision: June 27, 2000 Incidence of Malignant Pleural Mesothelioma due to Environmental Asbestos Fiber Exposure

More information

Malignant Mesothelioma Versus Metastatic Carcinoma of the Pleura: A CT Challenge

Malignant Mesothelioma Versus Metastatic Carcinoma of the Pleura: A CT Challenge Iran J Radiol. 2016 January; 13(1): e10949. Published online 2015 November 14. CHEST IMAGING DOI: 10.5812/iranjradiol.10949 Research Article Malignant Mesothelioma Versus Metastatic Carcinoma of the Pleura:

More information

Objectives. Mylene T. Truong, MD. Malignant Pleural Mesothelioma Background

Objectives. Mylene T. Truong, MD. Malignant Pleural Mesothelioma Background Imaging of Pleural Tumors Mylene T. Truong, MD Imaging of Pleural Tumours Mylene T. Truong, M. D. University of Texas M.D. Anderson Cancer Center, Houston, TX Objectives To review tumors involving the

More information

Extrapleural Pneumonectomy for Malignant Mesothelioma: Pro. Joon H. Lee 9/17/2012

Extrapleural Pneumonectomy for Malignant Mesothelioma: Pro. Joon H. Lee 9/17/2012 Extrapleural Pneumonectomy for Malignant Mesothelioma: Pro Joon H. Lee 9/17/2012 Malignant Pleural Mesothelioma (Epidemiology) Incidence: 7/mil (Japan) to 40/mil (Australia) Attributed secondary to asbestos

More information

HEALTH CARE FOR EXPOSURE TO ASBESTOS. 2010 The SafetyNet Centre for Occupational Health and Safety Research Memorial University www.safetynet.mun.

HEALTH CARE FOR EXPOSURE TO ASBESTOS. 2010 The SafetyNet Centre for Occupational Health and Safety Research Memorial University www.safetynet.mun. HEALTH CARE FOR PATIENTS WITH EXPOSURE TO ASBESTOS 2010 The SafetyNet Centre for Occupational Health and Safety Research Memorial University www.safetynet.mun.ca HEALTH CARE FOR PATIENTS WITH EXPOSURE

More information

Sternotomy and removal of the tumor

Sternotomy and removal of the tumor Sternotomy and removal of the tumor All thymomas originate from epithelial thymic cells 4% of them consist of a pure population of epithelial cells Most have mixed populations of lymphoid cells to a

More information

Primary -Benign - Malignant Secondary

Primary -Benign - Malignant Secondary TUMOURS OF THE LUNG Primary -Benign - Malignant Secondary The incidence of lung cancer has been increasing almost logarithmically and is now reaching epidemic levels. The overall cure rate is very low

More information

ASBESTOS EXPOSURE AND SARCOMATOID MALIGNANT PLEURAL MESOTHELIOMA Gorantla Sambasivarao 1, Namballa Usharani 2, Tupakula Suresh Babu 3

ASBESTOS EXPOSURE AND SARCOMATOID MALIGNANT PLEURAL MESOTHELIOMA Gorantla Sambasivarao 1, Namballa Usharani 2, Tupakula Suresh Babu 3 ASBESTOS EXPOSURE AND SARCOMATOID MALIGNANT PLEURAL MESOTHELIOMA Gorantla Sambasivarao 1, Namballa Usharani 2, Tupakula Suresh Babu 3 HOW TO CITE THIS ARTICLE: Gorantla Sambasivarao, Namballa Usharani,

More information

PET POSITIVE PLEURAL PLAQUES DECADES AFTER PLEURODESIS: MESOLTHELIOMA? Ellen A. Middleton 1. Jonathan C. Daniel 2. Kenneth S.

PET POSITIVE PLEURAL PLAQUES DECADES AFTER PLEURODESIS: MESOLTHELIOMA? Ellen A. Middleton 1. Jonathan C. Daniel 2. Kenneth S. PET POSITIVE PLEURAL PLAQUES DECADES AFTER PLEURODESIS: MESOLTHELIOMA? Ellen A. Middleton 1 Jonathan C. Daniel 2 Kenneth S. Knox 1 Kathleen Williams 1 Departments of Medicine 1 and Surgery 2, University

More information

Malignant Pleural Diseases Advances Clinicians Should Know F Gleeson

Malignant Pleural Diseases Advances Clinicians Should Know F Gleeson Malignant Pleural Diseases Advances Clinicians Should Know F Gleeson The following relevant disclosures, conflicts of interest and/ or financial relationships exist related to this presentation: Consultant

More information

Disease/Illness GUIDE TO ASBESTOS LUNG CANCER. What Is Asbestos Lung Cancer? www.simpsonmillar.co.uk Telephone 0844 858 3200

Disease/Illness GUIDE TO ASBESTOS LUNG CANCER. What Is Asbestos Lung Cancer? www.simpsonmillar.co.uk Telephone 0844 858 3200 GUIDE TO ASBESTOS LUNG CANCER What Is Asbestos Lung Cancer? Like tobacco smoking, exposure to asbestos can result in the development of lung cancer. Similarly, the risk of developing asbestos induced lung

More information

The Proposed New International TNM Staging System for Malignant Pleural Mesothelioma: Application to Imaging

The Proposed New International TNM Staging System for Malignant Pleural Mesothelioma: Application to Imaging 323.....:. #{149} :. #{149}..: #{149}. #{149}. :- : Received June 22, 1995; accepted after revision September 12, 1995. 1 Department of Radiology, Duke University Medical Center, Box 3808, Dunham, NC 2771

More information

Mesothelioma: Questions and Answers

Mesothelioma: Questions and Answers CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Mesothelioma: Questions

More information

Survey of Mesothelioma Associated with Asbestos Exposure in Japan

Survey of Mesothelioma Associated with Asbestos Exposure in Japan The research and development and the dissemination projects related to the 13 fields of occupational injuries and illnesses Survey of Mesothelioma Associated with Asbestos Exposure in Japan Clinical characteristics

More information

Uses and Abuses of Pathology in Asbestos-exposed Populations

Uses and Abuses of Pathology in Asbestos-exposed Populations Uses and Abuses of Pathology in Asbestos-exposed Populations Jerrold L. Abraham, MD Department of Pathology State University of New York Upstate Medical University Syracuse, NY, 13210 USA The term: Asbestosis,

More information

Tina Mosaferi, Harvard Medical School Year III Gillian Lieberman, MD

Tina Mosaferi, Harvard Medical School Year III Gillian Lieberman, MD July 2014 Tina Mosaferi, Harvard Medical School Year III 1. Our Patient-Introduction 2. Asbestos Basics 3. Pulmonary Findings Manifestations demonstrated by companion patients 4. Our patient-conclusion

More information

UKRC 2015 Dr Michael Sproule Glasgow

UKRC 2015 Dr Michael Sproule Glasgow UKRC 2015 Dr Michael Sproule Glasgow Radiology of Asbestos Related Lung Disease General term given to a group of fibrous minerals containing silica and a variety of other elements. Asbestos: Derived

More information

Asbestos Disease: An Overview for Clinicians Asbestos Exposure

Asbestos Disease: An Overview for Clinicians Asbestos Exposure Asbestos Asbestos Disease: An Overview for Clinicians Asbestos Exposure Asbestos: A health hazard Exposure to asbestos was a major occupational health hazard in the United States. The first large-scale

More information

Diseases. Inflammations Non-inflammatory pleural effusions Pneumothorax Tumours

Diseases. Inflammations Non-inflammatory pleural effusions Pneumothorax Tumours Pleura Visceral pleura covers lungs and extends into fissures Parietal pleura limits mediastinum and covers dome of diaphragm and inner aspect of chest wall. Two layers between them (pleural cavity) contains

More information

Recommendations for the Reporting of Pleural Mesothelioma

Recommendations for the Reporting of Pleural Mesothelioma Recommendations for the Reporting of Pleural Mesothelioma Association of Directors of Anatomic and Surgical Pathology * DOI: 10.1309/6A30YQHBMTHEJTEM It has been evident for decades that pathology reports

More information

Plueral Malignancy: Radiologic-pathologic

Plueral Malignancy: Radiologic-pathologic Plueral Malignancy: Radiologic-pathologic Correlation Ritu R. Gill, MD Pleural Malignancies: Radiologic-Pathologic Correlation Ritu R Gill MD Brigham and Women s Hospital Boston, Massachusetts Pleural

More information

The incidence of mesothelioma has not decreased for the last twenty years in Southeast region of Anatolia

The incidence of mesothelioma has not decreased for the last twenty years in Southeast region of Anatolia The incidence of mesothelioma has not decreased for the last twenty years in Southeast region of Anatolia Carkanat AI 1, *Abdurrahman A 1, Abakay O 2, Cengizhan S 1, Selimoglu SH 1, Senyigit A 1 1. Department

More information

Radiology of Asbestos-related Diseases

Radiology of Asbestos-related Diseases 8/25/03 9/19/03 Radiology of Asbestos-related Diseases Joan S. Hu,, Harvard Medical School Year III Gillian Lieberman, M.D. Asbestos-related conditions I. Benign Pleural Disease II. III. IV. A. Pleural

More information

INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER Prospective Mesothelioma Staging Project

INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER Prospective Mesothelioma Staging Project INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER Prospective Mesothelioma Staging Project Data Forms and Fields in CRAB Electronic Data Capture System - Reduced Set - Pivotal data elements for developing

More information

How To Prevent Asbestos Related Diseases

How To Prevent Asbestos Related Diseases BD5.3 Report of Working Groups Elimination of Asbestos-related Diseases ICOH 2012 March 18, 2012 Cancun Report of WG Elimination of Asbestos-related Diseases Dr. Sherson mail to ICOH President of 7 December

More information

Defending the Rest Basics on Lung Cancer, Other Cancers and Asbestosis: Review of the B-Read and Pulmonary Function Testing

Defending the Rest Basics on Lung Cancer, Other Cancers and Asbestosis: Review of the B-Read and Pulmonary Function Testing Defending the Rest Basics on Lung Cancer, Other Cancers and Asbestosis: Review of the B-Read and Pulmonary Function Testing ASBESTOSIS November 2013 Bruce T. Bishop Lucy L. Brandon Willcox & Savage 440

More information

Radiologic Assessment of Mesothelioma

Radiologic Assessment of Mesothelioma 28 Radiologic Assessment of Mesothelioma Samuel G. Armato III, Heber MacMahon, Geoffrey R. Oxnard, Charles L. Croteau, and Nicholas J. Vogelzang Imaging plays an essential role in the diagnosis, staging,

More information

SUMMARY OF S.B. 15 ASBESTOS/SILICA LITIGATION REFORM BILL

SUMMARY OF S.B. 15 ASBESTOS/SILICA LITIGATION REFORM BILL SUMMARY OF S.B. 15 ASBESTOS/SILICA LITIGATION REFORM BILL S.B. 15, the asbestos/silica litigation reform bill, distinguishes between the claims of people who are physically impaired or sick due to exposure

More information

by Lee S. Newman, M.D., and Cecile S. Rose, M.D., M.P.H.

by Lee S. Newman, M.D., and Cecile S. Rose, M.D., M.P.H. OCCUPATIONAL ASBESTOSIS AND RELATED DISEASES by Lee S. Newman, M.D., and Cecile S. Rose, M.D., M.P.H. A 63-year-old man consulted an internist complaining of dyspnea on exertion. He reported the following:

More information

Neoplasms of the LUNG and PLEURA

Neoplasms of the LUNG and PLEURA Neoplasms of the LUNG and PLEURA 2015-2016 FCDS Educational Webcast Series Steven Peace, BS, CTR September 19, 2015 2015 Focus o Anatomy o SSS 2000 o MPH Rules o AJCC TNM 1 Case 1 Case Vignette HISTORY:

More information

Interstitial lung disease in a rheumatic electrician

Interstitial lung disease in a rheumatic electrician Interstitial lung disease in a rheumatic electrician Case history The case presented here concerns a male, born in 1931, who was an electrician for 34 years. He had frequent and close contact with asbestos,

More information

Mesothelioma. 1995-2013, The Patient Education Institute, Inc. www.x-plain.com ocft0101 Last reviewed: 03/21/2013 1

Mesothelioma. 1995-2013, The Patient Education Institute, Inc. www.x-plain.com ocft0101 Last reviewed: 03/21/2013 1 Mesothelioma Introduction Mesothelioma is a type of cancer. It starts in the tissue that lines your lungs, stomach, heart, and other organs. This tissue is called mesothelium. Most people who get this

More information

Update on Mesothelioma

Update on Mesothelioma November 8, 2012 Update on Mesothelioma Intro incidence and nomenclature Update on Classification Diagnostic specimens Morphologic features Epithelioid Histology Biphasic Histology Immunohistochemical

More information

Cardiac Masses and Tumors

Cardiac Masses and Tumors Cardiac Masses and Tumors Question: What is the diagnosis? A. Aortic valve myxoma B. Papillary fibroelastoma C. Vegetation from Infective endocarditis D. Thrombus in transit E. None of the above Answer:

More information

CT findings in Differential Diagnosis between Tuberculous Pleurisy and Malignant Effusion

CT findings in Differential Diagnosis between Tuberculous Pleurisy and Malignant Effusion CT findings in Differential Diagnosis between Tuberculous Pleurisy and Malignant Effusion Poster No.: E-0084 Congress: ESTI 2012 Type: Scientific Exhibit Authors: S. S. Shim, Y. Kim; Seoul/KR Keywords:

More information

Assessment of 18 F-fluorodeoxyglucose dual-head gamma camera in asbestos lung diseases

Assessment of 18 F-fluorodeoxyglucose dual-head gamma camera in asbestos lung diseases Eur Respir J 2004; 24: 814 821 DOI: 10.1183/09031936.04.00004504 Printed in UK all rights reserved Copyright #ERS Journals Ltd 2004 European Respiratory Journal ISSN 0903-1936 Assessment of 18 F-fluorodeoxyglucose

More information

Asbestos related health risks

Asbestos related health risks Asbestos related health risks Pascal DUMORTIER *,** & Paul DE VUYST** *a-ulab ** Chest Department Hopital ERASME Asbestos related health risks Asbestos : some facts Asbestos related diseases Detection

More information

Surgeons Role in Symptom Management. A/Prof Cliff K. C. Choong Consultant Thoracic Surgeon Latrobe Regional Hospital GIPPSLAND

Surgeons Role in Symptom Management. A/Prof Cliff K. C. Choong Consultant Thoracic Surgeon Latrobe Regional Hospital GIPPSLAND Surgeons Role in Symptom Management A/Prof Cliff K. C. Choong Consultant Thoracic Surgeon Latrobe Regional Hospital GIPPSLAND Conditions PLEURAL Pleural effusion Pneumothorax ENDOBRONCHIAL Haemoptysis

More information

What is Mesothelioma?

What is Mesothelioma? What is Mesothelioma? Mesothelioma is a rare type of cancer that develops in the mesothelial cells found in one s body. These cells form membranous linings that surround and protect the body s organs and

More information

International Journal of Case Reports in Medicine

International Journal of Case Reports in Medicine International Journal of Case Reports in Medicine Vol. 2013 (2013), Article ID 409830, 15 minipages. DOI:10.5171/2013.409830 www.ibimapublishing.com Copyright 2013 Andrew Thomas Low, Iain Smith and Simon

More information

Clinical cases in Malignant Pleural Mesothelioma: Adherence to the ESMO Clinical Practice Guidelines

Clinical cases in Malignant Pleural Mesothelioma: Adherence to the ESMO Clinical Practice Guidelines Clinical cases in Malignant Pleural Mesothelioma: Adherence to the ESMO Clinical Practice Guidelines Wieneke Buikhuisen The Netherlands Cancer Institute Amsterdam The Netherlands Case (1) Male, 56 year

More information

MALIGNANT PLEURAL MESOTHELIOMA TREATED IN CLINIC FOR PULMONARY DISEASES AND TUBERCULOSIS PODHRASTOVI IN TEN-YEAR PERIOD ( FROM 1998 TO 2007 )

MALIGNANT PLEURAL MESOTHELIOMA TREATED IN CLINIC FOR PULMONARY DISEASES AND TUBERCULOSIS PODHRASTOVI IN TEN-YEAR PERIOD ( FROM 1998 TO 2007 ) & MALIGNANT PLEURAL MESOTHELIOMA TREATED IN CLINIC FOR PULMONARY DISEASES AND TUBERCULOSIS PODHRASTOVI IN TEN-YEAR PERIOD ( FROM 1998 TO 2007 ) Vesna Čukić*, Aida Ustamujić, Vladimir Lovre, Hasan Žutić,

More information

WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 1894/06

WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 1894/06 WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 1894/06 BEFORE: R. Nairn : Vice-Chair HEARING: September 25, 2006 at Windsor Oral DATE OF DECISION: October 16, 2006 NEUTRAL CITATION: 2006

More information

بسم هللا الرحمن الرحيم

بسم هللا الرحمن الرحيم بسم هللا الرحمن الرحيم Updates in Mesothelioma By Samieh Amer, MD Professor of Cardiothoracic Surgery Faculty of Medicine, Cairo University History Wagner and his colleagues (1960) 33 cases of mesothelioma

More information

Francine Lortie-Monette, MD, MSc, CSPQ, MBA Department of Epidemiology and Biostatistics University of Western Ontario 2003

Francine Lortie-Monette, MD, MSc, CSPQ, MBA Department of Epidemiology and Biostatistics University of Western Ontario 2003 ASBESTOS Francine Lortie-Monette, MD, MSc, CSPQ, MBA Department of Epidemiology and Biostatistics University of Western Ontario 2003 Asbestosis Asbestosis is a model for other dust diseases as well as

More information

Asbestos and your lungs

Asbestos and your lungs This information describes what asbestos is and the lung conditions that are caused by exposure to it. It also includes information about what to do if you have been exposed to asbestos, and the benefits

More information

Basic Data. 鍾 XX, female Age:59 y/o

Basic Data. 鍾 XX, female Age:59 y/o Basic Data 鍾 XX, female Age:59 y/o Chief complain for evaluation of the left pleural mass Clinical course This 59 years old lady Hypertension for 3 years, under herbal control. An episode of high BP up

More information

Determination of Asbestos Exposure by Pathology and Clinical History

Determination of Asbestos Exposure by Pathology and Clinical History 16 Determination of Asbestos Exposure by Pathology and Clinical History Allen R. Gibbs The determination of whether an abnormal asbestos exposure took place is important in mesothelioma cases because of

More information

Male. Female. Death rates from lung cancer in USA

Male. Female. Death rates from lung cancer in USA Male Female Death rates from lung cancer in USA Smoking represents an interesting combination of an entrenched industry and a clearly drug-induced cancer Tobacco Use in the US, 1900-2000 5000 100 Per Capita

More information

GUIDELINES FOR THE MANAGEMENT OF LUNG CANCER

GUIDELINES FOR THE MANAGEMENT OF LUNG CANCER GUIDELINES FOR THE MANAGEMENT OF LUNG CANCER BY Ali Shamseddine, MD (Coordinator); as04@aub.edu.lb Fady Geara, MD Bassem Shabb, MD Ghassan Jamaleddine, MD CLINICAL PRACTICE GUIDELINES FOR THE TREATMENT

More information

Malignant Mesothelioma State of the Art

Malignant Mesothelioma State of the Art Malignant Mesothelioma State of the Art Paul Baas The Netherlands Cancer Institute August 12, 2011, Carlsbad, CA Summary Diagnosis; epithelial type subdivided Pleiomorphic vs other Staging: IASLC-IMIG

More information

Small Cell Lung Cancer

Small Cell Lung Cancer Small Cell Lung Cancer Types of Lung Cancer Non-small cell carcinoma (NSCC) (87%) Adenocarcinoma (38%) Squamous cell (20%) Large cell (5%) Small cell carcinoma (13%) Small cell lung cancer is virtually

More information

Thoracoscopy in Pleural Malignant Mesothelioma

Thoracoscopy in Pleural Malignant Mesothelioma Diagnostic and Therapeutic Endoscopy, 1997, Vol. 3, pp. 147-151 Reprints available directly from the publisher Photocopying permitted by license only (C) 1997 OPA (Overseas Publishers Association) Amsterdam

More information

Malignant Mesothelioma Diagnosed by Bronchoscopic Biopsy

Malignant Mesothelioma Diagnosed by Bronchoscopic Biopsy CASE REPORT http://dx.doi.org/10.4046/trd.2015.78.3.297 ISSN: 1738-3536(Print)/2005-6184(Online) Tuberc Respir Dis 2015;78:297-301 Malignant Mesothelioma Diagnosed by Bronchoscopic Biopsy Yeon-Hee Park,

More information

Introduction. Case Report

Introduction. Case Report DOI: 10.4046/trd.2009.67.4.369 ISSN: 1738-3536(Print)/2005-6184(Online) Tuberc Respir Dis 2009;67:369-373 CopyrightC2009. The Korean Academy of Tuberculosis and Respiratory Diseases. All rights reserved.

More information

Malignant Mesothelioma Current Approaches to a Difficult Problem. Raja M Flores, MD Thoracic Surgery Memorial Sloan-Kettering Cancer Center

Malignant Mesothelioma Current Approaches to a Difficult Problem. Raja M Flores, MD Thoracic Surgery Memorial Sloan-Kettering Cancer Center Malignant Mesothelioma Current Approaches to a Difficult Problem Raja M Flores, MD Thoracic Surgery Memorial Sloan-Kettering Cancer Center Malignant Pleural Mesothelioma Clinical Presentation Insidious

More information

Round Table with Drs. Anne Tsao and Alex Farivar, Case 2: Mesothelioma

Round Table with Drs. Anne Tsao and Alex Farivar, Case 2: Mesothelioma Round Table with Drs. Anne Tsao and Alex Farivar, Case 2: Mesothelioma I d like to welcome everyone, thanks for coming out to our lunch with experts. The faculty today are great people in the thoracic

More information

Mesothelioma. 1. Introduction. 1.1 General Information and Aetiology

Mesothelioma. 1. Introduction. 1.1 General Information and Aetiology Mesothelioma 1. Introduction 1.1 General Information and Aetiology Mesotheliomas are tumours that arise from the mesothelial cells of the pleura, peritoneum, pericardium or tunica vaginalis [1]. Most are

More information

Use of imaging in the management of malignant pleural mesothelioma

Use of imaging in the management of malignant pleural mesothelioma Clinical Radiology (2005) 60, 1237 1247 REVIEW Use of imaging in the management of malignant pleural mesothelioma R.E. Benamore a, M.J. O Doherty b, J.J. Entwisle a, * a Department of Radiology, University

More information

J of Evidence Based Med & Hlthcare, pissn- 2349-2562, eissn- 2349-2570/ Vol. 2/Issue 33/Aug. 17, 2015 Page 5063

J of Evidence Based Med & Hlthcare, pissn- 2349-2562, eissn- 2349-2570/ Vol. 2/Issue 33/Aug. 17, 2015 Page 5063 PERITONEAL MALIGNANT MESOTHELIOMA: A RARE S. R. Dhamotharan 1, S. Shanthi Nirmala 2, F. Celine Foustina Mary 3, M. Arul Raj Kumar 4, R. Vinothprabhu 5 HOW TO CITE THIS ARTICLE: S. R. Dhamotharan, S. Shanthi

More information

MESOTHELIOMA. Not Just a Late Night Commercial. Graciela Hoal, RN, MSN, ACNP-BC

MESOTHELIOMA. Not Just a Late Night Commercial. Graciela Hoal, RN, MSN, ACNP-BC MESOTHELIOMA Not Just a Late Night Commercial Graciela Hoal, RN, MSN, ACNP-BC Saturday Session Thoracic Surgery Nurse Practitioner Greater Los Angeles Veteran Affairs Objectives Course Objectives: Discuss

More information

Is CT screening for asbestos-related diseases rational?

Is CT screening for asbestos-related diseases rational? Is CT screening for asbestos-related diseases rational? Narufumi Suganuma, M.D. 1 Yukinori Kusaka, M.D. 1 Harumi Itoh, M.D. 2 1 Division of Environmental Health, Department of International, Social and

More information

Malignant pleural mesothelioma is a rare primary neoplasm,

Malignant pleural mesothelioma is a rare primary neoplasm, Assessment of Malignant Pleural Mesothelioma with F-FDG Dual-Head Gamma-Camera Coincidence Imaging: Comparison with Histopathology Victor H. Gerbaudo, PhD 1 ; David J. Sugarbaker, MD 2 ; Scott Britz-Cunningham,

More information

3- B ~ E. Asbestos-Related Respiratory Diseases

3- B ~ E. Asbestos-Related Respiratory Diseases 3- B ~ E. Asbestos-Related Respiratory Diseases Takumi Kishimoto Deputy-director, Okayama Rosai Hospital, Japan Summary For the pulmonary diseases arising from asbestos there are benign lesions from asbestosis

More information

General Rules SEER Summary Stage 2000. Objectives. What is Staging? 5/8/2014

General Rules SEER Summary Stage 2000. Objectives. What is Staging? 5/8/2014 General Rules SEER Summary Stage 2000 Linda Mulvihill Public Health Advisor NCRA Annual Meeting May 2014 National Center for Chronic Disease Prevention and Health Promotion Division of Cancer Prevention

More information

SMALL CELL LUNG CANCER

SMALL CELL LUNG CANCER Protocol for Planning and Treatment The process to be followed in the management of: SMALL CELL LUNG CANCER Patient information given at each stage following agreed information pathway 1. DIAGNOSIS New

More information

Understanding Pleural Mesothelioma

Understanding Pleural Mesothelioma Understanding Pleural Mesothelioma UHN Information for patients and families Read this booklet to learn about: What is pleural mesothelioma? What causes it? What are the symptoms? What tests are done to

More information

Therapy of pleural effusions Modern techniques

Therapy of pleural effusions Modern techniques Therapy of pleural effusions Modern techniques Dr. Melanie Toffel Sugery of the chest Pleural effusion Ethiology In the normal pleural space there is a steady state in which there is a roughly equal rate

More information

WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 1557/14

WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 1557/14 WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 1557/14 BEFORE: M. Crystal: Vice-Chair HEARING: August 20, 2014 at Toronto Written DATE OF DECISION: December 4, 2014 NEUTRAL CITATION: 2014

More information

Diagnostic Imaging and workup of Malignant Pleural Mesothelioma.

Diagnostic Imaging and workup of Malignant Pleural Mesothelioma. Diagnostic Imaging and workup of Malignant Pleural Mesothelioma. A pictorial essay Luciano Cardinale, Francesco Ardissone*, Dario Gned, Nicola Sverzellati**, Edoardo Piacibello, Andrea Veltri Department

More information

Malignant Pleural Mesothelioma Diagnosed by Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration

Malignant Pleural Mesothelioma Diagnosed by Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration http://dx.doi.org/10.4046/trd.2013.74.2.74 ISSN: 1738-3536(Print)/2005-6184(Online) Tuberc Respir Dis 2013;74:74-78 CopyrightC2013. The Korean Academy of Tuberculosis and Respiratory Diseases. All rights

More information

PARTICLE SIZE AND CHEMISTRY:

PARTICLE SIZE AND CHEMISTRY: Pneumoconioses LW/Please note: This information is additional to Davidson s Principles and Practice of Medicine. /Hierdie inligting is aanvullend tot Davidson s Principles and Practice of Medicine. Pneumoconioses

More information

Cytology : first alert of mesothelioma? Professor B. Weynand, UCL Yvoir, Belgium

Cytology : first alert of mesothelioma? Professor B. Weynand, UCL Yvoir, Belgium Cytology : first alert of mesothelioma? Professor B. Weynand, UCL Yvoir, Belgium Introduction 3 cavities with the same embryologic origin the mesoderme Pleura Exudates Pleura Peritoneum Pericardium 22%

More information

How To Treat Lung Cancer At Cleveland Clinic

How To Treat Lung Cancer At Cleveland Clinic Treatment Guide Lung Cancer Management The Chest Cancer Center at Cleveland Clinic, which includes specialists from the Respiratory Institute, Taussig Cancer Institute and Miller Family Heart & Vascular

More information

WA Asbestos Review Program

WA Asbestos Review Program WA Asbestos Review Program Dr Fraser Brims Consultant Respiratory Physician, SCGH, Head of Occupational and Respiratory Health Unit, LIWA Asbestos awareness week seminar, 2014 Introduction Asbestos and

More information

Health Effects of Asbestos Exposure

Health Effects of Asbestos Exposure Health Effects of Asbestos Exposure Jill Dyken, PhD, PE John Wheeler, PhD, DABT Agency for Toxic Substances and Disease Registry Asbestos Science Seminar Folsom, California August 18-19, 2004 Agency for

More information

Imaging of pleural and chest wall tumors

Imaging of pleural and chest wall tumors Thorac Surg Clin 14 (2004) 15 23 Imaging of pleural and chest wall tumors Michael J. Weyant, MD a, Raja M. Flores, MD a,b, * a Cardiothoracic Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York

More information

FREQUENTLY ASKED QUESTIONS about asbestos related diseases

FREQUENTLY ASKED QUESTIONS about asbestos related diseases FREQUENTLY ASKED QUESTIONS about asbestos related diseases 1. What are the main types of asbestos lung disease? In the human body, asbestos affects the lungs most of all. It can affect both the spongy

More information

Treatment of mesothelioma in Bloemfontein, South Africa

Treatment of mesothelioma in Bloemfontein, South Africa European Journal of Cardio-thoracic Surgery 24 (2003) 434 440 www.elsevier.com/locate/ejcts Treatment of mesothelioma in Bloemfontein, South Africa W.J. de Vries*, M.A. Long Cardiothoracic Department,

More information

Case Report A Cause of Bilateral Chylothorax: A Case of Mesothelioma without Pleural Involvement during Initial Diagnosis

Case Report A Cause of Bilateral Chylothorax: A Case of Mesothelioma without Pleural Involvement during Initial Diagnosis Case Reports in Pulmonology Volume 2015, Article ID 962504, 4 pages http://dx.doi.org/10.1155/2015/962504 Case Report A Cause of Bilateral Chylothorax: A Case of Mesothelioma without Pleural Involvement

More information

Linfoma maligno pulmonar tratado com Nerium oleander. http://www.drozel.org/eng/diagnosis_malignant_mg.htm CASE REPORT

Linfoma maligno pulmonar tratado com Nerium oleander. http://www.drozel.org/eng/diagnosis_malignant_mg.htm CASE REPORT Linfoma maligno pulmonar tratado com Nerium oleander http://www.drozel.org/eng/diagnosis_malignant_mg.htm CASE REPORT Diagnosis: Malignant lymphoma, lung cancer A 60-year-old woman experienced pain in

More information

Malignant Mesothelioma

Malignant Mesothelioma Malignant Mesothelioma What is malignant mesothelioma? Malignant mesothelioma is a cancer that starts in cells in the linings of certain parts of the body, especially in the linings of the chest or abdomen.

More information

WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 171/08

WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 171/08 WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 171/08 BEFORE: M.F. Keil : Vice-Chair M. Christie: Member Representative of Employers M. Ferrari: Member Representative of Workers HEARING:

More information

Asbestos Related Diseases

Asbestos Related Diseases Asbestos Related Diseases Asbestosis Mesothelioma Lung Cancer Pleural Disease Asbestosis and Mesothelioma (LUNG CANCER) Support Group 1800 017 758 www.amsg.com.au ii Helping you and your family through

More information

A Diagnostic Chest XRay: Multiple Myeloma

A Diagnostic Chest XRay: Multiple Myeloma Daniela Marinho Tridente, VI FCMSCSP October 2013 A Diagnostic Chest XRay: Multiple Myeloma Daniela Marinho Tridente, VI FCMSCSP Our Learning Agenda Introduction of our patient His imaging data and findings

More information

Lung Cancer. This reference summary will help you better understand lung cancer and the treatment options that are available.

Lung Cancer. This reference summary will help you better understand lung cancer and the treatment options that are available. Lung Cancer Introduction Lung cancer is the number one cancer killer of men and women. Over 165,000 people die of lung cancer every year in the United States. Most cases of lung cancer are related to cigarette

More information

Summary of treatment benefits

Summary of treatment benefits Risk Management Plan PEMETREXED Powder for concentrate for Solution for infusion Pemetrexed is also indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non small cell

More information

Fact sheet Lung cancer screening for employees exposed to asbestos using CT screening (CTTS)

Fact sheet Lung cancer screening for employees exposed to asbestos using CT screening (CTTS) Version: February 2013 Fact sheet Lung cancer screening for employees exposed to asbestos using CT screening (CTTS) Dr. med. Susanna Stöhr, PD Dr. med. Dr. phil. David Miedinger, Dr. med. Marcel Jost 1.

More information

Determination of Environmental Exposure to Asbestos (Tremolite) and Mesothelioma Risks in the Southeastern Region of Turkey

Determination of Environmental Exposure to Asbestos (Tremolite) and Mesothelioma Risks in the Southeastern Region of Turkey Determination of Environmental Exposure to Asbestos (Tremolite) and Mesothelioma Risks in the Southeastern Region of Turkey ABDURRAHMAN SENYIGIT Dicle University Faculty of Medicine Department of Chest

More information

Multi-slice Helical CT Scanning of the Chest

Multi-slice Helical CT Scanning of the Chest Multi-slice Helical CT Scanning of the Chest Comparison of different low-dose acquisitions Lung cancer is the main cause of deaths due to cancer in human males and the incidence is constantly increasing.

More information

GENERAL CODING. When you review old cases that were coded to unknown, make corrections based on guidelines in effect at the time of diagnosis.

GENERAL CODING. When you review old cases that were coded to unknown, make corrections based on guidelines in effect at the time of diagnosis. GENERAL CODING When you review old cases that were coded to unknown, make corrections based on guidelines in effect at the time of diagnosis. Exception: You must review and revise EOD coding for prostate

More information

Malignant pleural mesothelioma P/D vs. EPP

Malignant pleural mesothelioma P/D vs. EPP 3 rd International Thoracic Oncology Congress Dresden, September 13 15, 2012 Malignant pleural mesothelioma P/D vs. EPP Walter Weder, MD Professor of Surgery Dokumentenname Datum Seite 1 Extrapleural Pneumonectomy

More information

Pleural Mesotheliomas in Sprague-D~wley Rats by Erionite: First Experimental Evidence

Pleural Mesotheliomas in Sprague-D~wley Rats by Erionite: First Experimental Evidence ENVIRONMENTAL RESEARCH 29, 238-244 (1982) Pleural Mesotheliomas in Sprague-D~wley Rats by Erionite: First Experimental Evidence CESARE MALTONI, FRANCO MINARDI, AND LEONILDO MORISI Institute oj Oncology,

More information

ASBESTOS DISEASES. Dr Alastair Robertson

ASBESTOS DISEASES. Dr Alastair Robertson ASBESTOS DISEASES Dr Alastair Robertson Occupational Health Department University Hospital Birmingham Birmingham B29 6JF 01216278285 Alastair.robertson@uhb.nhs.uk Occupational Lung Disease Unit Birmingham

More information

More than 2,500 people are diagnosed with mesothelioma in the UK each year.

More than 2,500 people are diagnosed with mesothelioma in the UK each year. This information is an extract from the booklet Understanding mesothelioma. You may find the full booklet helpful. We can send you a free copy see page 5. Contents Introduction Pleural mesothelioma Peritoneal

More information

Sir William Osler: Listen to the patient; the patient tells you everything.

Sir William Osler: Listen to the patient; the patient tells you everything. Sir William Osler: Listen to the patient; the patient tells you everything. Jean-Martin Charcot: The patient is a liar. Epidemiology of Mesothelioma Jeffrey H. Mandel, MD, MPH Division of Environmental

More information

Screening, early referral and treatment for asbestos related cancer

Screening, early referral and treatment for asbestos related cancer Screening, early referral and treatment for asbestos related cancer Marc de Perrot, MD, MSc, FRCSC Toronto Mesothelioma Research Program University of Toronto Asbestos related diseases Mesothelioma Lung

More information

Mesothelioma: Current Perspectives

Mesothelioma: Current Perspectives Refer to: Taylor RA, Johnson LP: : Current J>cr-, jpcclivej. West J Med 13 THEWESTEEN Journal of Medicine X'

More information

Clinicopathological Study on Malignant Pleural Mesotheliomas

Clinicopathological Study on Malignant Pleural Mesotheliomas Table of Contents Clinicopathological Study on Malignant Pleural Mesotheliomas PL-4-03 Kenzo Hiroshima Kenzo Hiroshima 1, Akira Iyota 1, Kiyoshi Sibuya 1, Toshikazu Yusa 2, Takehiko Fujisawa 1 and Yukio

More information